Salute e Benessere

Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder…

Tiotropium Bromide Inhalation Powder (RLD Spiriva®) had estimated annual sales of USD 42 million in Canada (IQVIA MAT Q4 of 2022). Tiotropium Bromide Inhalation Powder (RLD Spiriva®) had estimated annual sales ofUSD 42 millioninCanada(IQVIA MAT Q4 of 2022). About Lupin Lupin is an innovation-led transnational pharmaceutical company headquartered inMumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products,...
PR Newswire
11/07/2023

DISCOVERY LIFE SCIENCES ACCELERATES CLINICAL TRIALS WITH ADDITION OF…

The addition of clinical flow cytometry strengthens Discovery's position as a leading specialty contract laboratory. Researchers will now benefit from advanced instrumentation that enables the simultaneous analysis of up to 40 color combinations, significantly enhancing efficiency and accuracy in their clinical trial data collection and analysis. The addition of clinical flow cytometry strengthens Discovery's position as a leading specialty contract laboratory. Researchers will now benefit…
PR Newswire
11/07/2023

Neuraxpharm expands outside Europe into Brazil and Mexico

BARCELONA, Spain and DÜSSELDORF, Germany, July 11, 2023 /PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, today announces the establishment of affiliates in Brazil and Mexico, the two largest pharmaceutical markets in Latin America1, as first steps in its expansion outside of Europe. BARCELONA, Spainand DÜSSELDORF,Germany,July 11, 2023/PRNewswire/ -- Neuraxpharm Group...
PR Newswire
11/07/2023

Mendus publishes prospectus regarding previously announced rights issue and…

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. On June 8, 2023, Mendus AB...
Nasdaq GlobeNewswire
11/07/2023

Apple Tree Partners Recruits Noted Biotech Entrepreneur and Computer-Aided Drug…

NEW YORK and SOUTH SAN FRANCISCO, Calif., July 11, 2023 /PRNewswire/ -- Apple Tree Partners (ATP), a leader in life sciences venture capital, announced today thatMatthew P. Jacobson, Ph.D., serial biotech entrepreneur and Professor Emeritus in the Department of Pharmaceutical Chemistry at University of California San Francisco (UCSF), has joined ATP as a venture partner. In this role, he will identify opportunities for new life sciences investments and company creation and provide strategic…
PR Newswire
11/07/2023

Akari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan…

Akari has completed evaluation of long-acting PAS-nomacopan candidates and selected a single drug candidate to move forward into clinical trials for treatment of geographic atrophy (GA)The company remains on track for an IND submission in the first half of 2024 and the start of clinical trials in the second half of 2024Akari has selected Wacker Biotech GmbH as the manufacturing partner to support production of PAS-nomacopan for use in clinical trialsNEW YORK and LONDON, July11, 2023...
Nasdaq GlobeNewswire
11/07/2023

Sybleu Inc. Purchases Fifty Percent Stake In Patent Protected Small Molecule…

"By using these patent protected compounds as part of the training dataset for our in-licensed AI/ML engine, we expect to create additional compounds that are specific for activation and inhibition of the NR2F6 receptor and which are already optimized for additional properties such as toxicity and solubility," said Harry Lander, Ph.D., CSO of Sybleu. "This will potentially save years of drug screening and chemical optimization work from the drug development pathway as well as…
PR Newswire
11/07/2023

ADC Therapeutics Announces Voluntary Pause of Enrollment in the Phase 2 LOTIS-9…

®(loncastuximab tesirine-lpyl) and rituximab (Lonca-R) in unfit or frail patients with previously untreated diffuse large B-cell lymphoma (DLBCL).The voluntary action was taken by the Company after a recent review of aggregate data of the 40 patients enrolled in the trial and consultation with the Data Monitoring Committee (DMC) which signaled potentially excessive respiratory-related events. These respiratory-related treatment-emergent adverse events (TEAEs) included seven Grade 5 fatal...
Nasdaq GlobeNewswire
11/07/2023

AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo…

StemPrintER outperformed the current market leader, OncotypeDX test, in stratifying patients according to their risk of breast cancer recurrence LONDON and PHOENIX, July11, 2023(GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, signs further agreement with the IEO, one of the most renowned comprehensive cancer centers in Europe. This important milestone will support the company's...
Nasdaq GlobeNewswire
11/07/2023

Idefirix (imlifidase) receives provisional approval in Australia as…

Søren Tulstrup, President and CEO, Hansa Biopharma said, "With nearly 28 percent5 of kidney transplant candidates in Australia considered highly sensitized, the approval of Idefirix represents an important innovation in kidney transplantation care for patients and clinicians. Hansa applauds the TGA for being the first regulatory body to approve the use of Idefirix in transplants from both living and deceased donors, thus ensuring comprehensive access for highly sensitized patients in…
PR Newswire
11/07/2023

Design & Features To Drive Demand for Smart Bathroom Products In The U.S.A. - A…

The survey observed that consumers in the age group of 55-64 years find enhanced aesthetics and design to be the most influential factor driving their decision to purchase smart bathroom products, with a share of 21.3 percent, followed by convenience of use with nearly 18 percent. The survey observed that consumers in the age group of 55-64 years find enhanced aesthetics and design to be the most influential factor driving their decision to purchase smart bathroom products, with a share of 21...
PR Newswire
11/07/2023

Life Science Analytics Industry Exemplifies Commitment to Sustainable Reporting…

A concerted and sustainable effort to expedite replacement, reduction and refinement to foster new research models, approaches and tools has panned well. Several organizations are banking on diversity to minimize attrition rates and employees who prioritize environmental issues and social factors for good health. Furthermore, policymakers, consumers, employees, investors and venture capitalists have prioritized transparency, leadership behavior, opportunities and pay parity. A concerted and...
PR Newswire
11/07/2023

Invitation: Sobi's Q2 2023 report

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call. The presentation can be followed livehere or afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call. To participate in the conference call, please use the following dial-in details:Sweden : +46 8 5051 0031United Kingdom : +44 207 107 06 13United States : +1 631 570 56 13 For other countries,...
PR Newswire
11/07/2023

Global Stem Cell Market Projected to Reach $14 Bn by 2028: Ken Research

Interested to Know More about this Report, Request a Free Sample Report Interested to Know More about this Report, Request a Free Sample Report 2. The Growth of Stem Cell Banking Market inAsia Pacific : Rising Prevalence of Chronic Diseases Spurs Novel Therapeutic Technologies. Visit this Link :- Request for custom report Market Taxonomy By Source By Service Type Request free 30 minutes analyst call By Application By Cell Type By Region...
PR Newswire
11/07/2023

GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship…

The rebranding of both the Company and its products carries two powerful connotations. First, Morphic Medical's devices empower patients to "morph" into a healthier state, effectively combating diabetes and obesity to improve metabolic health and management of their disease. Additionally, the Company has undergone a significant evolution, aligning its strategy and approach with the current understanding of the disease. Morphic Medical's commitment to advancing healthcare has driven…
PR Newswire
11/07/2023

The Community of Madrid Selects Essence SmartCare to Provide Advanced Remote…

Essence SmartCare will bring remote care solutions and capabilities to the majority of the region's vulnerable population. The joint initiative will establish a cohesive infrastructure for care, replacing current analogue systems used for home telecare services with Essence's digital platform. Advanced devices, sensors and services provide information to create a remote care management platform, significantly expanding the possibilities of traditional 'red button' telecare. The new AI-enabled…
PR Newswire
11/07/2023

NHS approves ReMedi Health Solutions to assist UK Trusts as they continue their…

"We are thrilled to be approved as an NHS Digital Outcomes supplier," said Jenn Hamilton, RN-BC, MHA, CPHIMS, Executive Vice President of ReMedi Health Solutions. "Our team of experienced clinicians and healthcare IT professionals is passionate about advancing EPR modernisation through peer-based methods, and we're committed to improving the EPR experience for healthcare organisations and clinicians across the UK. We eagerly anticipate the opportunity to contribute our extensive…
PR Newswire
11/07/2023

Versameb Strengthens its Board of Directors

Dr Klaas Zuideveld, Chief Executive Officer of Versameb, said: "The experience of Hernán, Lily, Paul and Alexandre significantly strengthens the board of directors as we advance our lead candidate, VMB-100 for the treatment of SUI, into clinical development and further expand our technology platform, Versagile, with the development of two new discovery programs. Each of the new board members will add knowledge and expertise in all areas of the business as we ramp up for an exciting year of…
PR Newswire
11/07/2023

SKF Half-year report to be published on 19 July

To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers. To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers. Link to web event:https://www.investis-live.com/skf/648982e267ddff0c002ef682/andn Sweden +46 10 884 80 16 UK / International +44 20 3936 2999 Passcode: �� 466190 All information regarding the...
PR Newswire
11/07/2023

Revolutionary AI-Powered Diagnostics Platform PMcardio Now Accessible to…

PMcardio, a leading force in AI-powered diagnostics for cardiovascular diseases, announces expansion into 15 additional European markets with the launch of its newest version.After a successful initial launch in the United Kingdom, with over 25 000 registered users, PMcardio is now making its state-of-the-art application accessible to healthcare professionals inGermany, France, Belgium, The Netherlands, Austria, Switzerland, Portugal, Italy, Luxembourg, Lichtenstein, Cyprus, Poland,...
Nasdaq GlobeNewswire
11/07/2023

Korea Ginseng Corp. changed its brand name to Jung Kwan Jang

In the first issue of Philosophical Transactions published by the Royal Society, scientist Thévenot called ginseng a remarkable energy restorative and booster. In 1681, the Royal Family Collection Catalogue stated, "Ginseng does not grow everywhere. It grows only in Korea. It is used for treating chronic and serious diseases. It is very expensive and equivalent to silver in value." In the first issue of Philosophical Transactions published by the Royal Society, scientist Thévenot…
PR Newswire
11/07/2023

Casino Group: Update on new money equity offers

Update on new money equity offers Paris, 11 July 2023Casino announces that EP Global Commerce a.s. and Fimalac, together with 3F Holding, have extended the validity of their respective offers, filed on July 4 2023, to 12 July 2023. ***This press release was prepared solely for information purposes and should not be construed as a solicitation or an offer to buy or sell securities or related financial instruments. Likewise, it does not provide and should not be treated as providing...
Nasdaq GlobeNewswire
11/07/2023

metabion expands production capacity for diagnostic and therapeutic…

The investment is in the double-digit million EURO range and includes ISO 8 and 7 classified state-of-the-art clean room areas. Applied and certified standards are ISO 9001:2015, ISO 13485:2016 and EXCiPACT® GMP/GDP:2021. The investment is in the double-digit million EURO range and includes ISO 8 and 7 classified state-of-the-art clean room areas. Applied and certified standards are ISO 9001:2015, ISO 13485:2016 and EXCiPACT®...
PR Newswire
11/07/2023

Eurobio Scientific: Capital reduction through cancellation of treasury shares

Capital reduction through cancellation of treasury shares Cancellation of 400,000 treasury shares, representing approximately 3.53% of the share capital Paris, July 11, 2023 –7:30 amEurobio Scientific(FR0013240934, ALERS, PEA-PME eligible), a leading French group inin vitrospecialty medical diagnostics and life sciences, today announced that it has cancelled 400,000 of its own shares, representing 3.53% of the share capital, pursuant to the...
Nasdaq GlobeNewswire
11/07/2023
Altri  Comunicati